Teva Pharmaceutical Industries Ltd (NYSE: TEVA)
| Last Price | $32.76 |
| Net Change | $0.29 (0.89%) |
| Bid | $0 |
| Ask Price | $0 |
| Open Price | $32.51 |
| Previous Close Price | $32.47 |
| High Price | $32.91 |
| Low Price | $32.5 |
| Number of Trades | 14,558 |
| Volume | 4,028,776 |
| Fifty Two Week High | $55.79 (2016-08-04) |
| Fifty Two Week Low | $27.59 (2017-05-31) |
| Average Daily Volume | 8,848,547 |
| Share Outstanding | 1,016,000 Shares |
| Total Dividend Payout | 1.16/yr |
| Dividend Yield | 3.56% |
| 1st Quarter Earnings | $1.06 (2017-05-11) |
| 2nd Quarter Earnings | $1.38 (2017-02-13) |
| 3nd Quarter Earnings | $1.31 (2016-11-15) |
| 4th Quarter Earnings | $1.25 (2016-08-04) |
| PE Ratio | $6.59 |
| EPS Growth | $-7.77 |
| Recent Earnings | $1.06 |
| Annual EPS | $4.92 |
| Last Quarter EPS | $ |
| Market Capitalization | $33.16B |
| Insider Shareholders % | 0.071% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 1,016,000 |
| Inst. Shareholder % | 56.19% |
| Annual Net Income | $0B |
| TTM Net Profit Margin | $-129 |
| 1-Year Return | -38.44% |
| 3-Year Return | -36.02% |
| 5-Year Return | -8.23% |
| 5-Year Revenue Growth | 19.61% |
| 5-Year Earnings Growth | 1.81% |
| 5-Year Dividend Growth | 48.72% |
| Annual Dividend | $1.16 |
| Annual Dividend Yield | 3.54% |
| Change in EPS YTD | -7.77% |
| Dividends per Share | $0.289 |
| Stock Split Ratio | 2-1 |
| Beta | 0.47 |
TEVA News & Stock Updates
July 6, 2017
3 Biotech Stocks to Buy Now for Up to 270% GrowthJune 6, 2017
The 3 Best Pharmaceutical Stocks to Buy in 2017June 1, 2017
How Mylan Stole $1.27 Billion from Taxpayers and Rewarded Its Top ExecsApril 20, 2017
Why Indian Startups Are Targeting This New $5 Billion MarketMarch 23, 2017
Top Stocks to Watch Today: SGYP, PVH, NBIX